Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CREST UK: CPX-351 Real-World Effectiveness and Safety Study

NCT05169307 is registered in ClinicalTrials.gov with Jazz Pharmaceuticals as lead sponsor.

NCT NCT05169307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05169307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CREST UK: CPX-351 Real-World Effectiveness and Safety Study
Lead sponsor
Jazz Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
January 14, 2022
Completion date
June 15, 2022
Enrollment
147 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia